Rare diseases
Investigational molecules
Locations
Back to Spain330 clinical trials in Salt, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)A study of YL201 and atezolizumab for patients with advanced solid tumors
SpainA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
SpainStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
SpainEvaluation of Lymphocyte-Sparing Radiotherapy and All-Trans Retinoic Acid in Lateralized Oropharyngeal, Laryngeal, and Hypopharyngeal Squamous Cell Carcinoma
SpainEvaluation of mRNA-4359 Monotherapy and Combined Pembrolizumab Therapy in Advanced Solid Tumors: A Phase 1/2 Clinical Trial
SpainA Study of Camizestrant and Ribociclib for Patients with Hormone Receptor-Positive Breast Cancer
SpainStudy of Trastuzumab Deruxtecan Versus Chemotherapy as Additional Treatment After Surgery for Patients with HER2-Positive Endometrial Cancer
SpainA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
SpainStudy of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back
SpainStudy of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer
SpainA study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis
SpainA Study of Mirvetuximab Soravtansine, Carboplatin, and Bevacizumab in Adults with Ovarian Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on relapsing-remitting multiple sclerosis and its treatment approaches, including comparative studies of novel therapies and established medications.
Multiple innovative therapies are being evaluated to improve patient outcomes and reduce disease progression.
Dedicated research into Primary Progressive Multiple Sclerosis (PPMS), exploring new therapeutic options through targeted treatment approaches.
Studies focus on developing treatments to delay disability progression in PPMS patients.
Research addressing specific medical conditions including severe primary hand hyperhidrosis and pregnancy-related conditions such as nausea and vomiting.
Clinical investigations aim to enhance treatment options and patient comfort across various conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
